SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001494650-22-000124
Filing Date
2022-11-23
Accepted
2022-11-23 16:09:02
Documents
21
Period of Report
2022-11-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K optn-20221121.htm   iXBRL 8-K 50386
2 EX-1.1 exhibit11-underwritingagre.htm EX-1.1 526309
3 EX-4.1 exhibit41-formofwarrant112.htm EX-4.1 174825
4 EX-4.2 exhibit42-warrantagencyagr.htm EX-4.2 111904
5 EX-5.1 exhibit51-hoganopinion.htm EX-5.1 17968
6 EX-99.1 exhibit991-pressreleasexof.htm EX-99.1 10640
7 EX-99.2 exhibit992-pressreleasexpr.htm EX-99.2 11890
11 GRAPHIC image_0.jpg GRAPHIC 9505
12 GRAPHIC image_02.jpg GRAPHIC 28105
13 GRAPHIC optn-20221121_g1.jpg GRAPHIC 10067
  Complete submission text file 0001494650-22-000124.txt   1300059

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20221121.xsd EX-101.SCH 1902
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20221121_lab.xml EX-101.LAB 25848
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20221121_pre.xml EX-101.PRE 13581
15 EXTRACTED XBRL INSTANCE DOCUMENT optn-20221121_htm.xml XML 11806
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 221416419
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences